Clinical trial
Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy
NCT04575935 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 5, 2020
- Completion date
- December 31, 2028
- Enrollment
- 580 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
advanced ovarian carcinoma, fallopian tube clear cell adenocarcinoma, fallopian tube endometrioid tumor, fallopian tube serous neoplasm, fallopian tube transitional cell carcinoma, ovarian clear cell adenocarcinoma, ovarian endometrioid adenocarcinoma, ovarian serous adenocarcinoma, ovarian transitional cell carcinoma, primary peritoneal clear cell adenocarcinoma, primary peritoneal endometrioid adenocarcinoma, primary peritoneal serous adenocarcinoma, primary peritoneal transitional cell carcinoma, stage iiic fallopian tube cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic primary peritoneal cancer ajcc v8, stage iv fallopian tube cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv primary peritoneal cancer ajcc v8, stage iva fallopian tube cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva primary peritoneal cancer ajcc v8, stage ivb fallopian tube cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb primary peritoneal cancer ajcc v8